Ephedrine to treat intraoperative hypotension in infants: what is the target?

Br J Anaesth. 2023 May;130(5):510-515. doi: 10.1016/j.bja.2023.02.007. Epub 2023 Mar 9.

Abstract

Off-label use of medications in paediatric anaesthesia is common practice, owing to the relative paucity of evidence-based dosing regimens in children. Well-performed dose-finding studies, especially in infants, are rare and urgently needed. Unanticipated effects can result when paediatric dosing is based on adult parameters or local traditions. A recent dose-finding study on ephedrine highlights the uniqueness of paediatric dosing in comparison with adult dosing. We discuss the problems of off-label medication use and the lack of evidence for various definitions of hypotension and associated treatment strategies in paediatric anaesthesia. What is the aim of treating hypotension associated with anaesthesia induction: restoring the MAP to awake baseline values or elevating it above a provisional hypotension threshold?

Keywords: encephalopathy; ephedrine; hypotension; off-label use; paediatric anaesthesia.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Anesthesia, Obstetrical*
  • Anesthesia, Spinal*
  • Child
  • Ephedrine / therapeutic use
  • Humans
  • Hypotension* / chemically induced
  • Hypotension* / drug therapy
  • Infant
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Ephedrine
  • Vasoconstrictor Agents